Synopsys Down Over 9%, on Pace for Largest Percent Decrease Since March 2020 — Data Talk
Synopsys, Inc. (SNPS) is currently at $491.70, down $48.98 or 9.06%
--Would be lowest close since Jan. 5, 2024, when it closed at $484.81
--On pace for largest percent decrease since March 16, 2020, when it fell 13.19%
--Currently down three of the past four days
--Currently down two consecutive days; down 11.93% over this period
--Worst two day stretch since the two days ending Aug. 20, 2004, when it fell 30.45%
--Down 4.51% year-to-date
--Down 20.86% from its all-time closing high of $621.30 on July 5, 2024
--Up 11.39% from 52 weeks ago (Aug. 4, 2023), when it closed at $441.42
--Down 20.86% from its 52-week closing high of $621.30 on July 5, 2024
--Up 15.94% from its 52-week closing low of $424.10 on Aug. 17, 2023
--Traded as low as $487.40; lowest intraday level since Jan. 5, 2024, when it hit $477.65
--Down 9.85% at today's intraday low; largest intraday percent decrease since March 16, 2020, when it fell as much as 15.98%
--Eighth worst performer in the S&P 500 today
--Seventh worst performer in the Nasdaq 100 today
All data as of 11:00:19 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 02, 2024 11:18 ET (15:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks